• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.

作者信息

Wanner Christoph, Herzog Charles A, Turakhia Mintu P

机构信息

Division of Nephrology, Department of Medicine, University Hospital of Würzburg, Würzburg, Germany.

Division of Cardiology, Department of Medicine, Hennepin County Medical Center and University of Minnesota, Minneapolis, Minnesota, USA, and Chronic Disease Research Group, Minneapolis Medical Research Foundation, Minneapolis, Minnesota, USA.

出版信息

Kidney Int. 2018 Aug;94(2):231-234. doi: 10.1016/j.kint.2018.05.005. Epub 2018 Jun 21.

DOI:10.1016/j.kint.2018.05.005
PMID:29935952
Abstract
摘要

相似文献

1
Chronic kidney disease and arrhythmias: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病与心律失常：改善全球肾脏病预后组织（KDIGO）争议会议要点
Kidney Int. 2018 Aug;94(2):231-234. doi: 10.1016/j.kint.2018.05.005. Epub 2018 Jun 21.
2
Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病与心律失常：来自改善全球肾脏病预后组织（KDIGO）争议会议的结论
Eur Heart J. 2018 Jun 21;39(24):2314-2325. doi: 10.1093/eurheartj/ehy060.
3
Coronary artery disease in chronic kidney disease: highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.慢性肾脏病中的冠状动脉疾病：来自改善全球肾脏病预后组织（KDIGO）争议会议的要点
Kidney Int. 2020 Apr;97(4):642-644. doi: 10.1016/j.kint.2019.12.010. Epub 2019 Dec 28.
4
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).慢性肾脏病中的心血管疾病。KDIGO（改善全球肾脏病预后组织）的临床更新。
Kidney Int. 2011 Sep;80(6):572-86. doi: 10.1038/ki.2011.223. Epub 2011 Jul 13.
5
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report.慢性肾脏病的定义、分类和预后：KDIGO 争议会议报告。
Kidney Int. 2011 Jul;80(1):17-28. doi: 10.1038/ki.2010.483. Epub 2010 Dec 8.
6
Chronic Kidney Disease and Cerebrovascular Disease: Consensus and Guidance From a KDIGO Controversies Conference.慢性肾脏病与脑血管疾病：KDIGO 争议会议的共识与指南
Stroke. 2021 Jul;52(7):e328-e346. doi: 10.1161/STROKEAHA.120.029680. Epub 2021 Jun 3.
7
[Cardiac arrhythmias in patients with chronic kidney disease].[慢性肾脏病患者的心律失常]
Herzschrittmacherther Elektrophysiol. 2019 Sep;30(3):251-255. doi: 10.1007/s00399-019-0631-1. Epub 2019 Jul 23.
8
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).KDIGO 美国评论：2017 年 KDIGO 慢性肾脏病-矿物质和骨异常（CKD-MBD）诊治临床实践指南更新。
Am J Kidney Dis. 2017 Dec;70(6):737-751. doi: 10.1053/j.ajkd.2017.07.019. Epub 2017 Sep 21.
9
Revisiting KDIGO clinical practice guideline on chronic kidney disease-mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference.重新审视 KDIGO 慢性肾脏病-矿物质和骨异常临床实践指南：来自肾脏病：改善全球预后争议会议的评论。
Kidney Int. 2015 Mar;87(3):502-28. doi: 10.1038/ki.2014.425. Epub 2015 Feb 4.
10
Management of patients with diabetes and CKD: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.糖尿病和 CKD 患者的管理：来自“肾脏病：改善全球预后”（KDIGO）争议会议的结论。
Kidney Int. 2016 Dec;90(6):1175-1183. doi: 10.1016/j.kint.2016.09.010.

引用本文的文献

1
Safety and efficacy of direct oral anticoagulants in chronic kidney disease: a meta-analysis.直接口服抗凝剂在慢性肾脏病中的安全性和有效性：一项荟萃分析。
Res Pract Thromb Haemost. 2024 Oct 9;8(7):102584. doi: 10.1016/j.rpth.2024.102584. eCollection 2024 Oct.
2
Anticoagulation in Chronic Kidney Disease.慢性肾脏病的抗凝治疗。
Drugs. 2024 Oct;84(10):1199-1218. doi: 10.1007/s40265-024-02077-6. Epub 2024 Aug 9.
3
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.透析患者慢性心力衰竭的管理：一条充满挑战但回报丰厚的道路。
Rev Cardiovasc Med. 2024 Jun 25;25(6):232. doi: 10.31083/j.rcm2506232. eCollection 2024 Jun.
4
Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation combined with chronic kidney disease: a systematic review and meta-analysis.直接口服抗凝剂在心房颤动合并慢性肾脏病患者中的疗效与安全性：一项系统评价和荟萃分析。
Thromb J. 2024 Apr 29;22(1):40. doi: 10.1186/s12959-024-00608-5.
5
Oral anticoagulation for stroke prevention in atrial fibrillation and advanced kidney disease.用于心房颤动和晚期肾病患者预防卒中的口服抗凝治疗
Res Pract Thromb Haemost. 2024 Feb 15;8(2):102350. doi: 10.1016/j.rpth.2024.102350. eCollection 2024 Feb.
6
Protocol for a randomised controlled trial comparing warfarin with no oral anticoagulation in patients with atrial fibrillation on chronic dialysis: the Danish Warfarin-Dialysis (DANWARD) trial.比较慢性透析伴心房颤动患者使用华法林与不使用口服抗凝剂的随机对照试验方案：丹麦华法林-透析（DANWARD）试验。
BMJ Open. 2024 Feb 26;14(2):e081961. doi: 10.1136/bmjopen-2023-081961.
7
Cardiac Device Therapy in Patients with Chronic Kidney Disease: An Update.慢性肾脏病患者的心脏装置治疗：最新进展
J Clin Med. 2024 Jan 17;13(2):516. doi: 10.3390/jcm13020516.
8
Choosing the right chronic medication for hemodialysis patients. A short ABC for the dialysis nephrologist.为血液透析患者选择合适的慢性药物。透析肾病学家的简短 ABC。
J Nephrol. 2023 Mar;36(2):521-536. doi: 10.1007/s40620-022-01477-9. Epub 2022 Dec 6.
9
Use of non-vitamin K antagonists oral anticoagulants in atrial fibrillation patients on dialysis.在接受透析的心房颤动患者中使用非维生素K拮抗剂口服抗凝药。
Front Cardiovasc Med. 2022 Sep 13;9:1005742. doi: 10.3389/fcvm.2022.1005742. eCollection 2022.
10
Coronary Artery Disease in Chronic Kidney Disease: Need for a Heart-Kidney Team-Based Approach.慢性肾脏病中的冠状动脉疾病：需要基于心肾团队的方法。
Eur Cardiol. 2021 Dec 7;16:e48. doi: 10.15420/ecr.2021.30. eCollection 2021 Feb.